AMBASSADOR Alliance A031501: Phase III randomized adjuvant study of pembrolizumab in muscle-invasive and locally advanced urothelial carcinoma (MIUC) vs observation Meeting Abstract


Authors: Apolo, A. B.; Ballman, K. V.; Sonpavde, G. P.; Berg, S. A.; Kim, W. Y.; Parikh, R. A.; Teo, M. Y.; Sweis, R. F.; Geynisman, D. M.; Grivas, P.; Chatta, G. S.; Reichert, Z. R.; Kim, J. W.; Bilen, M. A.; McGregor, B. A.; Srinivas, S.; Halabi, S.; Burbano, G. P.; Morris, M. J.; Rosenberg, J. E.; Alliance for Clinical Trials in Oncology
Abstract Title: AMBASSADOR Alliance A031501: Phase III randomized adjuvant study of pembrolizumab in muscle-invasive and locally advanced urothelial carcinoma (MIUC) vs observation
Meeting Title: 2024 ASCO Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 42
Issue: 4 Suppl.
Meeting Dates: 2024 Jan 25-27
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2024-02-01
Language: English
ACCESSION: WOS:001266676900417
DOI: 10.1200/JCO.2024.42.4_suppl.LBA531
PROVIDER: wos
Notes: Meeting Abstract: LBA531 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael Morris
    580 Morris
  2. Jonathan Eric Rosenberg
    513 Rosenberg
  3. Min Yuen   Teo
    105 Teo